Humphrey Bacchus's guest appearances

Humphrey Bacchus

Finding Genius Podcast

Fitter Food Radio

FutureTech Podcast

Cory Kidd

Charles C.J

Helius Medical Technologies

Daniel Pompa

Michael G. Surette

Katelyn Parsons

John Tucker

Meir Kryger

Erik Gunther

Ana Maiques

Ron Barshop

Kurt Schmidinger

Kim Kush

Sarah Hornsby

Stasha Gominak

OwlTail

Invivo provides diagnostic testing services that analyze the microbiome, host immune status, and genomic data. Humphrey Bacchus joins the podcast to discuss the following:  Why it’s important to understand the ways in which the internal microbiome is reflective of or correlated with the wider environment and ecosystems in which we live (e.g. soil, weather systems) What is unique about the approach being taken at Invivo, which includes a look at two microbiome types on which little commercial work has been done How the widely varying data sets in the field of microbiome research require clinicians to be well-read, well-versed, and well-supported to tease out the pertinent information and use it to the benefit of patients on an individual basis How vaginal microbiomes could affect or be related to female infertility, miscarriage, and preterm birth  About 10 years ago, Humphrey Bacchus joined Invivo, which at the time was just starting out in the field of microbiome research, testing microbiomes and figuring out how to apply what they were learning to the clinical arena for the benefit of patients. Bacchus quickly came to understand and appreciate the inseparable connection between our internal microbial ecosystems and the ecosystems within which we all live. “If we nurture these microbes rather than treat them as invaders, then we can watch after the wider environment in which we live,” says Bacchus. Ultimately, the focus at Invivo is on trying to help clinicians and patients understand the relationship their bodies have with various microbes in the development of the disease. While quite a lot of attention is being given to gastrointestinal microbiomes, Bacchus talks about the useful data being derived from a look at vaginal and oral microbiomes. He explains what markers are being looked at in order to evaluate host immune responses, and how necessary it is to understand that microbes do not exist in and of themselves but in relation to and in contact with the host’s immune system. Informed by this view, Bacchus and the team at Invivo aim to continue gathering as much data as possible while keeping in mind the dynamic complexity that cannot be ignored. To learn more, visit invivohealthcare.com.

Invivo provides diagnostic testing services that analyze the <a href="https://www.futuretechpodcast.com/podcasts/accelerating-microbiome-research-for-improved-human-health-dr-sandrine-miller-montgomery-uc-san-diego-center-for-microbiome-innovation/" rel="noopener nofollow" target="_blank">microbiome</a>, host immune status, and genomic data. Humphrey Bacchus joins the podcast to discuss the following: <ul> <li>Why it’s important to understand the ways in which the internal microbiome is reflective of or correlated with the wider environment and ecosystems in which we live (e.g. soil, weather systems)</li> <li>What is unique about the approach being taken at Invivo, which includes a look at two microbiome types on which little commercial work has been done</li> <li>How the widely varying data sets in the field of microbiome research require clinicians to be well-read, well-versed, and well-supported to tease out the pertinent information and use it to the benefit of patients on an individual basis</li> <li>How vaginal microbiomes could affect or be related to female infertility, miscarriage, and preterm birth</li> </ul> About 10 years ago, Humphrey Bacchus joined Invivo, which at the time was just starting out in the field of microbiome research, testing microbiomes and figuring out how to apply what they were learning to the clinical arena for the benefit of patients. Bacchus quickly came to understand and appreciate the inseparable connection between our internal microbial ecosystems and the ecosystems within which we all live. “If we nurture these microbes rather than treat them as invaders, then we can watch after the wider environment in which we live,” says Bacchus. Ultimately, the focus at Invivo is on trying to help clinicians and patients understand the relationship their bodies have with various microbes in the development of the disease. While quite a lot of attention is being given to gastrointestinal microbiomes, Bacchus talks about the useful data being derived from a look at vaginal and oral microbiomes. He explains what markers are being looked at in order to evaluate host immune responses, and how necessary it is to understand that microbes do not exist in and of themselves but in relation to and in contact with the host’s immune system. Informed by this view, Bacchus and the team at Invivo aim to continue gathering as much data as possible while keeping in mind the dynamic complexity that cannot be ignored. To learn more, visit <a href="http://invivohealthcare.com/" rel="noopener nofollow" target="_blank">invivohealthcare.com</a>.

Restoring Human Health and Ecology—Humphrey Bacchus—Invivo Diagnostics & Therapeutics

The team at Invivo takes a unique approach to the study of the microbiome that not only emphasizes the connection between internal microbial populations and the wider ecological community, but also focuses on two types of microbiomes where little commercial work has been done. Tune in to learn:  How the widely varying data sets in the field of microbiome research requires clinicians to be well-read, well-versed, and well-supported to tease out the pertinent information and use it to the benefit of patients on an individual basis Which microbiome factors and markers are being looked at most closely by the team at Invivo How vaginal microbiomes could affect or be related to female infertility, miscarriage, and preterm birth  About a decade ago, Invivo was just a small startup company, but it’s since become well-regarded in the world of microbiome research, particularly for the work being done to better inform patients through their clinicians about the ways in which microbes affect individual health statuses. The goal is to move  further from the idea that there’s a "pill for every ill" and instead help people to understand their internal ecosystem, how it’s interacting with their immune response and contributing to the development of disease, and how they might manipulate it in order to improve their health. In addition to looking at gastrointestinal microbiomes and trying to determine how to wield the data being derived in a way that will produce a clinical benefit for patients, the team at Invivo is also looking at the vaginal and oral microbiome. Bacchus shares the techniques they’re using to obtain data, the types of markers they’ve found to be most important in the vaginal microbiome, the importance of making sense of the data and educating clinicians to do the same for their patients, and how critical it is to understand that microbes cannot be understood when looked at as separate from the host’s immune response. Learn more at invivohealthcare.com.

The team at Invivo takes a unique approach to the study of the microbiome that not only emphasizes the connection between internal microbial populations and the wider ecological community, but also focuses on two types of microbiomes where little commercial work has been done. Tune in to learn: <ul> <li>How the widely varying data sets in the field of microbiome research requires clinicians to be well-read, well-versed, and well-supported to tease out the pertinent information and use it to the benefit of patients on an individual basis</li> <li>Which microbiome factors and markers are being looked at most closely by the team at Invivo</li> <li>How vaginal microbiomes could affect or be related to female infertility, miscarriage, and preterm birth</li> </ul> About a decade ago, Invivo was just a small startup company, but it’s since become well-regarded in the world of microbiome research, particularly for the work being done to better inform patients through their clinicians about the ways in which microbes affect individual health statuses. The goal is to move  further from the idea that there’s a "pill for every ill" and instead help people to understand their internal ecosystem, how it’s interacting with their immune response and contributing to the development of disease, and how they might manipulate it in order to improve their health. In addition to looking at gastrointestinal microbiomes and trying to determine how to wield the data being derived in a way that will produce a clinical benefit for patients, the team at Invivo is also looking at the vaginal and oral microbiome. Bacchus shares the techniques they’re using to obtain data, the types of markers they’ve found to be most important in the vaginal microbiome, the importance of making sense of the data and educating clinicians to do the same for their patients, and how critical it is to understand that microbes cannot be understood when looked at as separate from the host’s immune response. Learn more at <a href="http://invivohealthcare.com/" rel="nofollow" target="_blank">invivohealthcare.com</a>.

An Understanding of the Microbiome as Medicine—Humphrey Bacchus—Invivo Diagnostics & Therapeutics

In this Episode Keris and Matt discuss the GI-MAP, the latest innovation in gut testing offered by Invivo Clinical. Clinical Director Humphrey Bacchus explains the test in detail and an overview of the essential ingredients to good gut health.

Episode 88 - GI-MAP with Humphrey Bacchus